ロード中...
Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer
BACKGROUND: Selenite is a radiosensitizer and inhibitor of androgen receptor expression and function. In a phase I study (NCT02184533) in 15 subjects with metastatic cancer receiving daily oral sodium selenite with palliative radiation therapy, disease stabilization was observed, as evidenced by tum...
保存先:
| 出版年: | Drugs R D |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8206290/ https://ncbi.nlm.nih.gov/pubmed/33866531 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-021-00340-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|